High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma.
Chung
Hyun Woo
HW
Department of Nuclear Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, 4-12 Hwayang-dong, Kwangjin-gu, Seoul, Korea. hwchung@kuh.ac.kr
Lee
Eun Jeong
EJ
Cho
Yo-Han
YH
Yoon
So Young
SY
So
Young
Y
Kim
Sung-Yong
SY
Lee
Mark Hong
MH
Kim
Jeong Hwan
JH
Lee
Sun-Young
SY
Sung
In-Kyung
IK
Park
Hyung-Seok
HS
Yoo
Moon-Won
MW
Lee
Kyung-Yung
KY
D000230:Adenocarcinoma / Q000175:diagnosis / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics; D005500:Follow-Up Studies; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010166:Palliative Care / Q000379:methods / Q000706:statistics & numerical data; D049268:Positron-Emission Tomography / Q000379:methods*; D016016:Proportional Hazards Models; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed / Q000379:methods*; D016896:Treatment Outcome
D019788:Fluorodeoxyglucose F18